WCG Wealth Advisors LLC Boosts Position in Sanofi $SNY

WCG Wealth Advisors LLC lifted its stake in shares of Sanofi (NASDAQ:SNY) by 132.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,255 shares of the company’s stock after buying an additional 34,931 shares during the quarter. WCG Wealth Advisors LLC’s holdings in Sanofi were worth $2,969,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Flagship Harbor Advisors LLC purchased a new position in shares of Sanofi during the fourth quarter worth approximately $25,000. Measured Wealth Private Client Group LLC purchased a new stake in Sanofi in the 3rd quarter valued at $29,000. Palisade Asset Management LLC acquired a new stake in Sanofi during the 3rd quarter worth $30,000. Annis Gardner Whiting Capital Advisors LLC boosted its stake in Sanofi by 544.4% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the company’s stock worth $34,000 after purchasing an additional 588 shares during the period. Finally, Larson Financial Group LLC grew its position in Sanofi by 48.9% during the 4th quarter. Larson Financial Group LLC now owns 810 shares of the company’s stock worth $39,000 after purchasing an additional 266 shares during the last quarter. Hedge funds and other institutional investors own 14.03% of the company’s stock.

Sanofi Trading Up 4.7%

Shares of Sanofi stock opened at $44.38 on Friday. Sanofi has a 52-week low of $42.28 and a 52-week high of $52.68. The company’s 50-day simple moving average is $45.47 and its 200-day simple moving average is $46.77. The firm has a market cap of $107.60 billion, a price-to-earnings ratio of 12.40, a price-to-earnings-growth ratio of 1.04 and a beta of 0.34. The company has a quick ratio of 0.22, a current ratio of 1.01 and a debt-to-equity ratio of 0.17.

Sanofi Increases Dividend

The business also recently disclosed an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were paid a $2.4225 dividend. This represents a dividend yield of 559.0%. This is a positive change from Sanofi’s previous annual dividend of $2.04. The ex-dividend date was Monday, May 4th. Sanofi’s dividend payout ratio (DPR) is 49.16%.

Wall Street Analyst Weigh In

A number of research firms have commented on SNY. Citigroup restated a “neutral” rating on shares of Sanofi in a research note on Monday, April 13th. Wall Street Zen downgraded shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a report on Thursday, March 19th. Weiss Ratings upgraded Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. Finally, BNP Paribas Exane downgraded Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price objective for the company. in a research note on Monday, April 20th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sanofi has a consensus rating of “Hold” and an average target price of $51.00.

Sanofi Company Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.